Track topics on Twitter Track topics that are important to you
Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices) . Backed by premier venture investors, the Company is developing revolutionary systems to treat neurovascular disease - including brain aneurysms - which are simple, safe, cost-effective and curative.
Cerebrotech Medical Systems, an innovative medical device company focused on the development of a portable brain bioimpedance monitor, today announced that board member Mar...
Nfocus is developing the next generation treatment for brain aneurysms. The company's innovative LUNA(TM) product is a single-deployment, easy-to-use embolization device designed to be a direct replac...
Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices) . Backed by premier...
We have published hundreds of Nfocus Neuromedical Inc. news stories on BioPortfolio along with dozens of Nfocus Neuromedical Inc. Clinical Trials and PubMed Articles about Nfocus Neuromedical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nfocus Neuromedical Inc. Companies in our database. You can also find out about relevant Nfocus Neuromedical Inc. Drugs and Medications on this site too.
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...